Publication | Open Access
Eukaryotic translation initiation factor 3B accelerates the progression of esophageal squamous cell carcinoma by activating β-catenin signaling pathway
32
Citations
17
References
2016
Year
EIF3B might serve as a novel marker for predicting prognosis of ESCC patients and as a potential therapeutic target, individually or together with other subunits of EIF3 complex.
| Year | Citations | |
|---|---|---|
Page 1
Page 1